LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

Search

Denali Therapeutics Inc

Closed

Sector Healthcare

26.97 3.49

Overview

Share price change

24h

Current

Min

26.94

Max

27.23

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+49.54 upside

Dividends

By Dow Jones

Next Earnings

4 lis 2024

News Sentiment

By Acuity

34%

66%

105 / 389 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Strong Bearish Evidence

Denali Therapeutics Inc Chart

Past performance is not a reliable indicator of future results.

Related News

16 lut 2024, 16:40 UTC

Major Market Movers

Denali Therapeutics Shares Fall After ALS Treatment Misses Primary Endpoint

29 paź 2024, 21:31 UTC

Top News

AbbVie's Deal for Alzheimer's Antibody Raises Curtain for Roche News on Wednesday -- Barrons.com

Peer Comparison

Price change

Denali Therapeutics Inc Forecast

Price Target

By TipRanks

49.54% upside

12 Months Forecast

Average 40.45 USD  49.54%

High 90 USD

Low 22 USD

Based on 14 Wall Street analysts offering 12 month price targets forDenali Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

14 ratings

11

Buy

3

Hold

0

Sell

Technical Score

By Trading Central

25.94 / 27.78Support & Resistance

Short Term

Strong Bearish Evidence

Intermediate Term

Bearish Evidence

Long Term

No Evidence

Sentiment

By Acuity

105 / 389 Ranking in Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

$